Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MCRIP1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | PDLIM1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | CD53 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | P2RX2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | IDH3B | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | GDF6 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | FGFR1OP2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | ATP7B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | MARCH3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | NOP16 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |